Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: A prospective, randomized, placebo-controlled, double-blind pilot trial

Cancer

Volumn 117, Issue 16, 2011, Pages 3788-3795

  Kirste, Simon ^a   Treier, Markus ^a   Wehrle, Sabine Jolie ^a   Becker, Gerhild ^a   Abdel Tawab, Mona ^b   Gerbeth, Kathleen ^b   Hug, Martin Johannes ^a   Lubrich, Beate ^a   Grosu, Anca Ligia ^a   Momm, Felix ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b ABDA Bundesvereinigung Deutscher Apothekerverbande   (Germany)

Author keywords

Boswellia serrata; brain edema; brain tumor; radiotherapy; supportive care

Indexed keywords

BOSWELLIA SERRATA EXTRACT; BOSWELLIC ACID; DEXAMETHASONE; PLACEBO;

ADULT; AGED; ALOPECIA; ARTICLE; BOSWELLIA; BOSWELLIA SERRATA; BRAIN EDEMA; CANCER RADIOTHERAPY; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DERMATITIS; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG INDUCED HEADACHE; FEMALE; GASTROINTESTINAL SYMPTOM; GLIOBLASTOMA; HUMAN; MALE; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SECOND CANCER; SEIZURE;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BOSWELLIA; BRAIN EDEMA; BRAIN NEOPLASMS; COGNITION; DISEASE-FREE SURVIVAL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYTOTHERAPY; PILOT PROJECTS; PLACEBOS; QUALITY OF LIFE; TRITERPENES;

EID: 80051552444     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25945     Document Type: Article

References (24)

1. Streffer JR, Bitzer M, Schabet M, et al. Response of radiochemotherapy- associated cerebral edema to a phytotherapeutic agent, H15. Neurology. 2001; 56: 1219-1221. (Pubitemid 32405720)
2. Boeker DK, Winking M., The role of boswellic acids in therapy of malignant glioma [in German]. Dt Aerztebl. 1997; 94: 1197-1199.
3. Ernst E., Frankincense: systematic review. B Med J. 2008; 337: a2813.
4. Reising K, Meins J, Bastian B, et al. Determination of boswellic acids in brain and plasma by high performance liquid chromatography/tandem mass spectrometry. Anal Chem. 2005; 77: 6640-6645. (Pubitemid 41504448)
5. Buchele B, Zugmaier W, Simmet T., Analysis of pentacyclic triterpenic acids from frankincense gum resins and related phytopharmaceuticals by high performance liquid chromatography. Identification of lupeolic acid, a novel pentacyclic triterpene. J Chromatogr B Analyt Technol Biomed Life Sci. 2003; 791: 21-30. (Pubitemid 36638734)
6. Ennet D, Poetsch F, Groditsch D., Indian frankincense. Dtsch Apoth Ztg. 2000; 140: 105-113.
7. Martinez D, Lohs K, Janzen J., Incense and myrrh: cultural history and economic impact, botany, chemistry, medicine [German]. Stuttgart, Germany: Wissenschaftliche Verlagsgesellschaft mgH. 2009.
8. Poeckel D, Werz O., Boswellic acids: biological actions and molecular targets. Curr Med Chem. 2006; 13: 3359-3369. (Pubitemid 44873750)
9. Takada Y, Ichikawa H, Badmaev V, Aggarwal BB., Acetyl-11-keto-beta- boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B-regulated gene expression. J Immunol. 2006; 176: 3127-3140.
10. Kruger P, Daneshfar R, Eckert GP, et al. Metabolism of boswellic acids in vitro and in vivo. Drug Metab Dispos. 2008; 36: 1135-1142. (Pubitemid 351717472)
11. Poeckel D, Werz O., Boswellic acids: biological actions and molecular targets. Curr Med Chem. 2006; 13: 3359-3369. (Pubitemid 44873750)
12. Ammon HP., Boswellic acids in chronic inflammatory diseases. Planta Med. 2006; 72: 1100-1116. (Pubitemid 44638909)
13. Gupta I, Gupta V, Parihar A, et al. Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study. Eur J Med Res. 1998; 3: 511-514.
14. Sander O, Herborn G, Rau R., Is H15 (resin extract of Boswellia serrata, "incense") a useful supplement to established drug therapy of chronic polyarthritis? Results of a double-blind pilot study [in German]. Z Rheumatol. 1998; 57: 11-16.
15. Gerhardt H, Seifert F, Buvari P, et al. Therapy of active Crohn disease with Boswellia serrata extract H 15 [in German]. Z Gastroenterol. 2001; 39: 11-17. (Pubitemid 32125556)
16. Madisch A, Miehlke S, Eichele O, et al. Boswellia serrata extract for the treatment of collagenous colitis. A double-blind, randomized, placebo-controlled, multicenter trial. Int J Colorectal Dis. 2007; 22: 1445-1451. (Pubitemid 47543333)
17. Kimmatkar N, Thawani V, Hingorani L, Khiyani R., Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee-a randomized double blind placebo controlled trial. Phytomedicine. 2003; 10: 3-7. (Pubitemid 36262200)
18. Sontakke S, Thawani V, Pimpalkhute P, et al. Open, randomized, controlled clinical trial of Boswellia serrata extract as compared to valdecoxib in osteoarthritis of the knee. Indian Pharmacol. 2007; 39: 27-29. (Pubitemid 46381930)
19. Glaser T, Winter S, Groscurth P, et al. Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity. Br J Cancer. 1999; 80: 756-765. (Pubitemid 29209838)
20. Evans ML, Graham MM, Mahler PA, Rasey JS., Use of steroids to suppress vascular response to radiation. Int J Radiat Oncol Biol Phys. 1987; 13: 563-567. (Pubitemid 17069652)
21. Weller M, Schmidt C, Roth W, Dichgans J., Chemotherapy of human malignant glioma: prevention of efficacy by dexamethasone ? Neurology. 1997; 48: 1704-1709.
22. Sengupta K, Alluri KV, Satish AR, et al. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee. Arthritis Res Ther. 2008; 10: R85.
23. Sterk V, Buchele B, Simmet T., Effect of food intake on the bioavailability of boswellic acids from a herbal preparation in healthy volunteers. Planta Med. 2004; 70: 1155-1160. (Pubitemid 40101096)
24. Wettergren L, Kettis-Lindblad A, Sprangers M, Ring L., The use, feasibility and psychometric properties of an individualised quality-of-life instrument: a systematic review of the SEIQoL-DW. Qual Life Res. 2009; 18: 737-746.